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Abstract 
The somatic stability of cloned long-term cytolytic T lymphocyte lines (CTLL) specific for 
antigens encoded by murine cytomegalovirus (MCMV) was tracked for more than two years 
of continuous in vitro propagation. Clone Si retained its original specificity for a structural (S) 
antigen of MCMV for about eight months in the presence of antigen and interleukin 2 (IL 2), 
but not in IL 2 alone. In the following months, however, in spite of the continued presence of 
antigen, clonal variants developed that displayed distinct patterns of target cell recognition, 
including loss of the original specificity and acquisition of exclusive specificity for the natural 
killer target cell YAC-1. On the other hand, large granular lymphoblast (LGL) lines, line I E l -
IL and a series of sublines thereof, could be established that stably expressed Ld-restricted 
specificity for a viral nonstructural immediate-early (IE) antigen more than two years after 
withdrawal of antigen and feeder cells when propagated in the presence of pure recombinant 
human IL 2. The finding that the presence of antigen was not essential for the stability of clone 
IEl-derived CTLL indicates that maintenance of specificity in LGL lines is not a result of 
antigen-mediated selection, but reflects an intrinsic property. 
Introduction 
Based on different in vitro propagation requirements, three types of 
C T L L have been distinguished (for review, see ref. 1). Type 1 C T L L do not 
require external supply of I L 2, but depend on the presence of antigen. Such 
a state lasts only for a few weeks. Type 2 C T L L depend on both, antigen 
and I L 2, and can then be maintained for several months. Most long-term 
virus-specific C T L L reported so far belong to this group (2-5). Finally, 
C T L L growing in lymphokine-supplemented medium in the absence of 
feeder cells and antigen (6-8) are referred to as type 3 C T L L . Since virus-
Abbreviations: Con A = concanavalin A; CTL = cytolytic T lymphocyte(s); CTLL = CTL 
line(s); IE = immediate-early; IFN = interferon; IL2 = interleukin 2; LGL = large granular 
lymphoblast(s); LPS = lipopolysaccharide; \sIL2 = lymphokine supernatant IL 2; MCMV = 
murine cytomegalovirus; MHC = major histocompatibility complex; NK = natural killer; 
PFU = plaque-forming units; rhIL2 = recombinant (DNA) human IL2 ; U = units. 
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specific type 3 C T L L can be propagated in any laboratory without the need 
to establish the technology for viral infection, it should be an aim to select 
such C T L L as reference lines for the definition of virus-encoded epitopes. 
When compared with type 2 C T L L , however, the selection of influenza 
virus-specific type 3 C T L L proved to be a rare event (9), and type 3 clones 
in general were found to display profound changes in the karyotype (10), 
frequently associated with expression of nonspecific cytolytic activity (for 
review, see ref. 11). Degeneration of specificity to an NK-like (12), an aged 
killer (13) or an indiscriminate, promiscuous target cell recognition pattern 
was found to be accompanied by the acquisition of L G L morphology and 
an N K cell surface marker profile (for review, see ref. 14). It has been 
proposed recently that during adaptation to antigen-independent long-term 
growth in the only presence of lymphokines, C T L L invariably and rapidly 
lose the original specificity, supposedly due to overgrowing specificity loss 
variants (15). 
In this communication, we report on virus-specific type 3 C T L L with 
L G L morphology that could be established with relative ease and did not 
acquire the promiscuous reactivity predicted. Clone IE1, specific for the 
viral nonstructural I E membrane antigen of MCMV (16, 17), was selected in 
July 1984 (18), and deprived of antigen and feeder cells in November 1984. 
Since then, line I E 1 - I L and sublines thereof have been maintained continu-
ously in rhIL2 till now (March 1987) without losing viral antigen specific-
ity. The existence of such an L G L line contradicts published opinions. 
First, an L G L phenotype is not necessarily associated with nonspecific 
cytolytic activity, and second, antigen is not required for the maintenance 
of specificity in C T L L . 
Materials and Methods 
Propagation of CTLL 
Technical details regarding the selection of MCMV-specific CTL clones were given in a 
previous report (18). Line Si-A was split twofold in 6-day intervals and restimulated in 2-ml 
culture with 1 x 106 30-Gy y-ray-irradiated splenocytes, derived from MCMV-infected 
BALB/c (MHC-d) mice, and 1 x 105 PFU of infectious MCMV (ATCC VR-194, Smith strain) 
in the presence of 50 U of rhIL2 per ml. Line IE l - IL and its sublines were split likewise and 
maintained in the presence of 50 U of rhIL2 per ml without restimulation. The number of 
restimulations as well as of passages with IL 2 alone is coded in the form AnJLm with full 
stops indicating recloning (e.g. code A22IL11.9 signifies that the line has been recloned after 22 
restimulations followed by 11 passages in IL 2 alone, and was then maintained in IL 2 without 
antigen for further 9 passages). Lot 89050/84802 of rhIL2 (Sandoz Forschungsinstitut, Vienna, 
Austria) is > 99 % pure IL 2 (1.04 ± 0.35 ng of LPS per mg of protein) with a specific activity 
of 7.3 x 106 U/mg of protein normalized to a reference standard (lot ISP-841) supplied by the 
Biological Resources Branch at the National Cancer Institute, Frederick, MD, U.S.A. 
Recloning and statistical analyses 
Recloning was routinely done by seeding 0.5 cells per round-bottomed 96-tray (0.2 ml) 
microtiter well. The clone probability was calculated from the Poisson equation (19). In split 
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assays (see Table 1), the probability for an independent distribution of distinct monospecific 
clones (null hypothesis) was obtained by applying Fisher's exact probability test (20). 
Target cells and cytolytic assay 
The Moloney leukemia virus-induced T cell lymphoma of A/Sn (MHC-a, K k D d ) mice, 
YAC-1, was used to probe NK activity, and the methylcholanthrene-induced mastocytoma of 
DBA/2 (MHC-d) mice, P815, served to detect aged killer reactivity. Simian virus 40 (SV40)-
transformed kidney cells of B10.D2 (MHC-d) origin, KD2SV (21), and bovine papilloma 
virus-transformed fibroblasts derived from DBA/2 mice, DBA/2-BPV (provided by Dr. H . 
Pfister, Erlangen, F.R.G.), were used as probes for MCMV-specific CTL after either MCMV 
infection (multiplicity of 20 PFU/cell) under conditions of selective and enhanced expression 
of IE genes (IE-KD2SV and IE-DBA/2-BPV) or presentation of MCMV structural proteins 
(S-KD2SV) (16, 17). Specific lysis was determined in a standard 3-h 3 l Cr release assay. 
Cell surface phenotyping 
For cytofluorometric analysis of asialo-GMl expression, the CTL were labeled with rabbit 
anti-asialo-GMl serum gammaglobulin (0.1 mg per 106 cells; code no. 014-09801, Wako Pure 
Chemical Industries, Osaka, Japan). Fluorescein-conjugated F(ab)2 fragments of goat anti-
rabbit IgG (H and L chain-specific; Cat. No. 1312-0081, Cappel, Malvern, PA, U.S.A.) was 
used as second antibody. The relative fluorescence intensities of 104 viable cells measured with 
a fluorescence-activated cell sorter (FACS IV; Becton Dickinson FACS Systems, Sunnyvale, 
CA, U.S.A.) were expressed in a linear scale of 255 channels, and the fluorescence in the 
channel that separated the population in two halves is given in Table 5 to represent the median 
fluorescence of the population. 
Assay for I FN 
The supernatants of ten IE l - IL CTL cultures were pooled 4-6 days (about one population 
doubling) after seeding of 105 cells. At the time of harvesting, the differences in the average cell 
numbers between different lines did not exceed 40%. The IFN assay was performed 
essentially as described (22). IFN titers were expressed in international reference units (IU/ml) 
of murine IFN (NIH standard G-002-904-511). Sensitivity to pH 2 characterized the IFN as 
IFN-y. This result was confirmed by complete neutralization of the IFN activity with 
monoclonal anti murine IFN-y antibody (hybridoma R4-6A2 secreting IgGl ; kindly provided 
by Dr. Havell, Saranac Lake, NY, U.S.A.). 
Results 
Selection and attributes of the CTL clones SI and IE1 
The viral antigen specificity of these two clones has been reported 
previously (18). Clones were derived from mesenteric lymph nodes of 10-
month-old BALB/c mice which had been infected with M C M V as new-
borns and had established a latent infection after a period of persistent viral 
replication. Already when clones became first visible in microcultures after 
only five in vitro restimulations could two discrete morphologic pheno-
types be distinguished: clones of large lymphoblasts and clones of small, 
densely growing lymphocytes. After six months of periodic restimulation 
(stage A30), the cloned lines IE1-A (Fig. la) and Sl-A (Fig. lb) were 
inspected by electron microscopy. IE1 cells showed the characteristics of 
L G L with typical cytolytic granules (23), while Si cells were considerably 
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Fig. 1. Morphologic phenotype of the MCMV-specific CTL clones IEl and SI. Electron 
microscopic analysis of clone morphology. Clone IEl cells (a) are large granular lymphoblasts 
with a diameter of 16-17 jim, whereas clone Si cells (b) are considerably smaller in size and 
display a pronounced protopode-uropode polarity. Both bars represent 2 jam. Ultrathin 
sections were stained with uranyl acetate and lead citrate. 
smaller and displayed a pronounced polarity with a protopode occupied by 
the nucleus, a uropode containing the organelles, and one or more 
pseudopodia. The morphologic characteristics remained stable in clone Si 
for about eight months and apparently indefinitely in the L G L clone I E l . 
Both clones recognized a viral antigenic determinant specified by MCMV, 
the epitope SI of a structural antigen of the virus and the nonstructural I E 
epitope I E l , respectively, in conjunction with cellular (D)L d class I glyco-
protein, and expressed the surface markers Thy-1.2 and Lyt-2.2, but not 
Lyt-1.2 and L3T4 (18). Clone I E l was recently found to recognize L 
fibroblasts (MHC-k) cotransfected with the L d gene and the major I E gene 
of MCMV, gene iel, that codes for the regulatory, intranuclear phospho-
protein pp89 (24). Neither of these clones lysed ConA-induced lympho-
blasts of the congenic mouse strains BIO, B10.D2, B10.S, B10.BR, B10.Q, 
B10.M, B10.P, and B10.RIII (b, d, s, k, q, f, p, and r M H C haplotypes, 
respectively). 
Morphologic alteration and somatic variation of specificity within line 
SI-A 
Line Sl -A proved to be dependent on both, I L 2 and antigen. In the 
presence of I L 2 alone, cytolytic activity was gradually lost within two 
months (not shown). Continuous selection by restimulation with infectious 
virus and irradiated, primed splenocytes resulted in retention of cytolytic 
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activity, but not specificity. After 15 months of propagation (stage A78), 
the line displayed morphologic heterogeneity with a high proportion of 
L G L , and had acquired reactivity against the lymphoma YAC-1 . The 
synchronism of these alterations along with published experience concern-
ing the reactivity of L G L clones (reviewed in ref. 14) suggested L G L to be 
the mediators of that NK-like activity. To test this prediction, L G L clones 
and uropodial lymphocyte clones were separated by recloning and probed 
for cytolytic activity against the specific target S-KD2SV and the prototype 
N K target YAC-1 (Table 1). It was found that the parental line at that stage 
comprised four types of clones: the original type consisting of S-specific 
uropodial lymphocytes and, in addition, uropodial lymphocytes as well as 
L G L with dual specificity and, against all prospects, S-specific L G L . This 
result demonstrated that either reactivity can be associated with either 
morphologic phenotype, and thus proved that both alterations are independ-
ent events. 
With the aim to rescue clone Si in its original form, long-term lines were 
established from the four S-specific, uropodial subclones (see Table 1) of 
line S l -A (U1-U4, Table 2). When the lines were tested 3.5 months after 
recloning (stage A78.18), line S1-A-U4 had already begun to switch to the 
L G L phenotype, while line S1-A-U3 retained the original morphology for 
at least three further months. The reactivity pattern observed at stage 
A78.34 typified line S l - A - U l as NK-like with dual specificity for the 
Table 1. Independent 
line Sl-A 
segregation of morphologic phenotype and NK-like reactivity within 
Morphologic 
phenotype 
Number 
of clones 
Proportion of 
negative cultures 
(clone probability) 
Median value (range) of % 
specific target cell lysis 
S-KD2SV YAC-1 
Large granular 
lymphoblast 
24 [2]' 
12 
348/384 (0.952) 
29 (13-53) 
26 (17-35) 
20 (10-40) 
< SLb 
Uropodial 
lymphocyte 
9 [Of 
4 
371/384 (0.983) 
59 (46-65) 
36 (21-60) 
38 (11-52) 
< SLb 
Note: At stage A78, line Sl-A was recloned by seeding 0.5 cells in a 0.2 ml microculture along 
with feeder cells and infectious MCMV as antigen. After 3 weeks, microcultures screened 
positive for growth were split and quarter aliquots tested for cytolytic activity. 
a Data in brackets represent the statistically expected number of double-positive cultures as a 
consequence of non-clonality. Lysis of S-KD2SV and YAC-1 was mediated by the same 
clone, because the observed number of double-positive cultures could not be explained 
statistically (P < 10"9, Fisher's test). 
b Significance limit (upper 99% tolerance limit of spontaneous lysis) that was 5.2%. 
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Table 2. Somatic variation of specificity in Sl-A sublines 
Sl-A subline Morphologic Protocol code Target cells (% specific lysis at E/T 
phenotype3 ratios of 10-2.5-0.6:l)b 
S-KD2SV KD2SV YAC-1 P815 
Sl -A-Ul UL A 78.18 32-17-9 < SLC 11-5-3 _d 
UL A 78.26 25-15-8 < SL 11-8-4 < SL 
UL-LGL A 78.34 29-19-16 < SL 22-13-3 < SL 
S1-A-U2 UL A 78.18 34-13-7 < SL 6-4-1 _ 
UL A 78.26 27-21-11 8-5-0 13-9-4 < SL 
UL-LGL A 78.34 35-33-25 23-10-4 23-21-15 < SL 
S1-A-U3 UL A 78.18 26-17-7 < SL 34-18-6 _ 
UL A 78.26 27-15-11 < SL 22-12-8 < SL 
UL A 78.34 40-32-18 17-13-6 44-33-25 < SL 
S1-A-U4 UL-LGL A 78.18 40-18-12 < SL 21-11-5 _ 
LGL A 78.26 < SL < SL 20-10-3 < SL 
LGL A 78.34 < SL < SL 31-20-12 < SL 
a Uropodial lymphocyte (UL) or large granular lymphoblast (LGL), or intermediate forms 
(UL-LGL). 
b Mean value of six replicate determinations for each effector-to-target-cell (E/T) ratio tested. 
c Specific lysis below the significance limit (upper 95 % confidence limit for the mean value of 
spontaneous lysis) at the highest E/T ratio tested. 
d Not determined. 
specific target and YAC-1 . Lines S1-A-U2 and U3 represent a novel type of 
C T L characterized by the potential to lyse non-infected fibroblasts (includ-
ing non-transformed embryonal fibroblasts, not shown) which are resistant 
to YAC-type N K reactivity. The genesis of line S1-A-U4 proved that N K 
reactivity can be mediated by cells of the C T L lineage, as the original 
specificity for S antigen of MCMV converted into an exclusive specificity 
for YAC-1 . None of those variants lysed the NK-resistant aged killer target 
cell P815 (13). 
In conclusion, attempts to recover the original form of clone Si failed 
and, instead, three distinct target cell recognition patterns were found to 
have developed in formerly antigen-specific Sl-A subclones. 
Stability of specific cytolytic activity in long-term IE1 CTLL maintained in 
rhIL2 
As with clone SI, clone IE1 was first propagated by repeated restimula-
tions. At stage A22, line I E l - A was split, and a subline, designated I E l - I L , 
was maintained without virus or feeder cells in the presence of rhIL2. After 
withdrawal of I L 2 , I E l - A and I E l - I L cells inevitably died within 48 h, 
demonstrating that both lines were IL2-dependent. When assayed for 
426 • M. J. R E D D E H A S E , et al. 
Table 3. Long-term stability of lytic activity and specificity within IEl lines maintained in rhIL 2 
Experi- Effector Protocol Target cells (% specific lysis at E/T 
ment cell line code ratios of 10-2.5-0.6:!)3 
IE-KD2SV S-KD2SV KD2SV YAC-1 P815 
1 IE1-A A42 35-15-3 2 0 2 0 
IE1-IL A22IL20 39-17-6 3 1 0 1 
IE1.14-IL A22IL11.9 57-33-11 4 2 2 0 
IE1.18-IL A22IL11.9 43-25-8 1 1 2 3 
IE1.2ML A22IL11.9 56-35-14 4 2 4 2 
2 IE1.14-IL A22IL11.39 49-29-12 3 1 2 2 
IE1.18-IL A22IL11.39 41-24-11 2 0 0 1 
IE1.21-IL A22IL11.39 36-30-22 0 2 1 0 
IE1.18.15-IL A22IL11.21.18 63-46-35 0 1 2 0 
IE1.18.20-IL A22IL11.21.18 70-61-32 3 3 1 2 
IE1.18.34-IL A22IL11.21.18 51-44-31 1 4 2 2 
3 Mean values of six replicate determinations. In case of non-significant lysis, only the value for 
an effector-to-target-cell (E/T) ratio of 10 is shown. 
specificity after 20 passages in rhIL2 (4 mo, stage A22IL20), line I E l - I L 
displayed the same specificity pattern as did line I E l - A that had been 
further restimulated (Table 3, Expt. 1). In detail, both lines lysed KD2SV 
fibroblasts only when MCMV I E genes were expressed (target IE-KD2SV, 
but not KD2SV and S-KD2SV), and not YAC-1 or P815. After 11 passages 
in rhIL2, line I E l - I L was recloned (26 of 384 cultures positive for growth; 
clone probability 0.965). Non-lytic variants were not observed, and all 
subclones had retained the original specificity. Three representative sublines 
(IE1.14-IL, IE1.18-IL, and IE1.21-IL) were established by long-term pro-
pagation in rhIL2, and assayed together with the parental lines at stage 
A22IL11.9 (Table 3, Expt. 1) as well as six months later at stage A22IL11.39 
(Table 3, Expt. 2). At stage A22IL11.21, subline IE1.18-IL was again 
recloned (37 of 384 cultures positive for growth; clone probability 0.950), 
and sublines thereof (IE1.18.15-IL, IE1.18.20-IL, and IEl.18.34-IL) were 
assayed at stage A22IL11.21.18 after a total of 50 passages (10 months) in 
rhIL2 without antigen (Table 3, Expt. 2). All sublines displayed exactly the 
specificity pattern of the parental lines, and none had developed NK-like, 
aged-killer, or promiscuous reactivity. This demonstrated that I L 2 was 
necessary and sufficient for the maintenance of cytolytic activity and 
specificity in the L G L clone I E l and all its descendants. 
Retention of specificity in presence of high doses of rhIL2 
Recent findings have indicated the induction of NK-like and promiscu-
ous reactivity in antigen-specific C T L clones by high doses of lymphokines 
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(12, 14). We therefore tested the disposition of the established C T L L 
IE1.18-IL to alter the pattern of target cell recognition under the influence 
of high doses of rhIL2. Table 4 documents that the specificity remained 
stable when the line was grown for one month (6 passages) in 500 U of 
rhIL2 per ml (4.4 nM), tenfold the amount used routinely for propagation. 
After two weeks, part of the line was exposed for further two weeks to 5000 
U of rhIL2 per ml, again without induction of significant NK-like or 
promiscuous reactivity. In detail, KD2SV as well as DBA/2-BPV fibro-
blasts were lysed only after expression of MCMV I E genes, and YAC-1 or 
P815 were not lysed. The same specificity pattern was observed when 
rhIL2 was replaced for one month by 40 % supernatant of lectin (Con A)-
induced rat lymphoblasts (lsIL 2) known to contain a variety of lympho-
kines. These data imply that line IE1.18-IL was refractory to an I L 2-
mediated change in specificity. It should be noted that prolonged propaga-
tion in lsIL2 (50 U of IL2/ml) resulted in a reduced growth and ultimately 
in the loss of the subline, suggesting that the use of rhIL 2 was essential for 
the long-term maintenance of line I E l - I L . 
Somatic variation of asialo-GMl expression and IFN-y secretion in line 
IEl-IL 
The glycolipid asialo-GMl has been regarded as a surface marker for 
NK-cells (25). Previous studies have shown that long-term C T L L can also 
display this marker (14). The demonstration of constitutive asialo-GMl 
expression in highly specific C T L L disproves a causal linkage between the 
presence of this glycolipid and NK-like function (compare Tables 4 and 5). 
At stage A22IL64, line IE1.18-IL and all its sublines still expressed Thy-1.2 
and Lyt-2.2 antigens (not shown), but varied in the degree of asialo-GMl 
Table 4. Invariant antigen specificity of line IE1.18-IL during exposure to high doses of IL 2 
Protocol code 
for line 
IE1.18-IL 
Lymphokine 
(U of IL 2/ml) 
Target cells (% speci ific lysis at E/T ratios of 10-1-0.1 : l ) a 
IE-
KD2SV 
KD2SV IE-DBA/ 
2-BPV 
DBA/ 
2-BPV 
YAC-1 P815 
A22IL11.53 rhIL2(50) b 50-45-20 2 52-35-16 0 1 1 
A22IL11.47(6)C rhIL2(500)b 46-34-14 1 48-31-11 3 6 2 
A22IL11.47 (3/3) rhIL 2 (500/5000) 31-10-5 3 47-17-1 0 4 3 
A22IL11.47(6) lsIL 2 (200)d 37-23-11 2 45-25-2 1 3 2 
a Mean values of six replicate determinations. 
b 6.8 and 68 ng (0.44 and 4.4 pmol) of pure IL 2/ml, respectively. 
c Numbers in parentheses indicate the number of passages in the high dose of lymphokine 
noted in the second column. 
d Lymphokine supernatant of Con A-stimulated rat lymphoblasts (lsIL 2), containing 500 U of 
I L 2/ml and 54 IU of IFN-y/ml besides other lymphokines that have not been quantitated. 
Residual Con A activity was blocked by adding a-methyl-mannoside (50 mM). 
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Table 5. Expression of the NK-cell surface marker asialo-GMl and secretion of IFN-y by 
I E l - I L sublines 
I E l - I L subline FA CS median channel fluorescence3 Titer of IFN-y b 
(U of rhIL 2/ml) IU/ml 
Control anti asialo-GMl 
1.18-IL (50) 20 91 54; 36 (<3 ; < 3) 
1.18.15-IL (50) 25 163 54; 54 (<3 ; < 3) 
1.18.20-IL (50) 15 26 18; 36 (<3 ; < 3) 
1.18.34-IL (50) 30 38 12; 12 (<3 ; < 3) 
1.18-IL (500) 22 231 162; 162 (<3 ; <3 ) c 
a Results are expressed as relative fluorescence intensities on a linear scale with 104 cells 
analyzed. Staining with FITC-labeled second antibody alone served as control. 
b Double determination. Values in parentheses represent the IFN titer after pH2 treatment. 
The detection limit was 3 IU/ml. Medium and rhIL 2 did not contain IFN. 
c Control experiments with up to 1 u.g of LPS per mg of IL 2 ensured that LPS present in the 
rhIL2 preparation (1 ng per mg of IL 2) did not induce IFN. 
expression. The fluorescence profile of line IE1.18-IL (not depicted) indi-
cated that the population comprised individual cells with an asialo-GMl 
expression ranging from almost negative to very high. On the population 
level, sublines stably displayed a higher (IEl.18.15) or lower (IEl.18.20 and 
I E l . 18.34) median fluorescence intensity than did the parental line. Expres-
sion of the glycolipid was elevated after exposure of the line for one month 
to 4.4 nM rhIL2 (500 U/ml). 
The variation in the amount of asialo-GMl detected at the cell membrane 
corresponded with the secretion of IFN-y. When maintained in 0.44 nM 
rhIL2, all lines displayed a low basic level of IFN-y secretion that was 
enhanced by cultivation in higher doses of I L 2. 
These findings indicated that somatic variation did occur in line I E l - I L , 
but, apparently, antigen recognition specificity was conserved. 
Discussion 
The selection of antigen-independent antiviral C T L L with constant 
specificity appears to be a rare event. TAYLOR and ASKONAS have pointed 
out in a recent review that they could keep only a single influenza-specific 
antigen-independent C T L L sufficiently long enough for detailed analysis, 
though a series of antigen-dependent clones were obtained with ease (9). 
Our long-term study on the cloning of C T L specific for antigens specified 
by MCMV, a member of the herpes virus group, has now documented 
long-term stability of antigen-independent C T L L in an essentially different 
virus system, thus confirming that selection of stable virus-specific type III 
C T L L is in principle reproducible. To our knowledge, the existence of 
antigen-independent C T L L has not been reported before for any other 
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herpes virus. With respect to the continuity of MHC-restricted cytolytic 
specificity in the absence of antigen and feeder cells, line I E l - I L and 
descendants thereof are without precedent among virus-specific C T L L . It is 
an important aspect that previous attempts to maintain C T L L have 
employed lsIL 2 comprising a variety of lymphokines/monokines, while 
line I E l - I L was propagated in purified rhIL2. We have experienced that 
replacement of rhIL2 by lsIL2 did not induce rapid alterations in the 
specificity or cytolytic activity of line IE1.18-IL (Table 4), but caused 
reduced growth, and ultimately resulted in the extinction of the line. The 
use of rhIL2 may therefore be crucial for a successful maintenance of 
antigen-independent C T L L . 
It has been proposed recently that stable expression of specificity in long-
term C T L L is a matter of antigen-mediated selection against clonal specific-
ity loss variants rather than the consequence of structural stability of the 
idiotypic T cell receptor (15). Consistent with that idea, line Sl-A retained 
specificity only when restimulated periodically with viral antigen. Later on, 
however, and without any apparent change in the propagation conditions, a 
spectrum of variants developed, including L G L that had lost the original 
specificity and had instead attained specificity for the NK-target YAC-1 . 
Thus, somatic variation in line Sl-A was finally able to override the 
counterselection by antigen. This proved to be a slow process, since 
recloning revealed a coexistence of ancestor-type C T L and variant C T L 
seven months after the first signs for specificity drift in that line. 
It is evident from our data that selection by antigen can be excluded as an 
explanation for the stability of specificity displayed by line I E l - I L . The 
objection that this clone might be autostimulatory by constitutively expres-
sing M C M V I E antigen can be refuted, because neither viral nucleic acid 
nor I E protein (pp89) was detectable (not shown). Transformation does not 
offer an alternative explanation either, since after withdrawal of I L 2 all I E l -
I L sublines inevitably died. Such a strict IL2-dependence is a strong 
criterion for a nontransformed state. 
It appears that uropodial type II C T L L have a programmed tendency to 
switch to the L G L phenotype that is characterized by a higher degree of 
cytoplasmic organization (Fig. 1), while a revert to uropodial morphology 
was not observed. This unidirectional development suggests that L G L 
represent the more mature, more specialized, and perhaps also the more 
stable type of C T L . The morphologic difference between antigen-depend-
ent type II and antigen-independent type III C T L L has been recognized 
before (7, 9). In this context, it is important to point out that clone IE1 was 
isolated from lymph nodes of latently MCMV-infected mice already as an 
L G L . Latent herpes virus infection provides a unique condition for the in 
vivo development of C T L clones, as reactivation events can result in 
frequent in vivo restimulation, generating C T L L in vivo. It could be 
speculated that selective expression of I E antigens during reactivation from 
viral latency (26) selectively favors the in vivo maturation of IE-specific 
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C T L clones, while S-specific C T L clones must be expected to outlast in a 
less developed state. Altogether, the genesis of clone I E l suggests that stable 
type III C T L clones exist in vivo and thus do not represent an artificial state 
attained only in vitro during long-term propagation. 
We hypothesize that, in vivo and in vitro, C T L clones undergo frequent 
somatic variation until reaching a more stable functional phenotype. This 
state appears to be signified by L G L morphology, regardless of the final 
recognition specificity. Cloning of those L G L whose terminal functional 
phenotype is the expression of MHC-restricted antigen-specificity should 
result in stable, IL2-dependent C T L L which can then serve as certifiable 
probes for the definition and identification of antigens. Work to test this 
prediction is in progress. 
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